Financials
- Market Capitalization 3.07 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.9
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1592 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 74.35 USD | +1.63% | -0.24% | -6.70% | +12.55% | 3.26 B USD | ||
| 1595 | CELC Celcuity Inc. - Common Stock | 65.21 USD | -4.02% | -11.89% | -21.76% | +39.19% | 3.19 B USD | ||
| 1626 | RCUS Arcus Biosciences, Inc. Common Stock | 24.33 USD | -0.37% | -1.86% | -1.42% | +53.99% | 3.10 B USD | ||
| 1639 | DYN Dyne Therapeutics, Inc. - Common Stock | 16.04 USD | -3.61% | +5.11% | -12.83% | -31.48% | 3.00 B USD |